Showing: 1 - 2 of 2 RESULTS

Diabetic Americans dispute Trump’s claim he made insulin so cheap ‘it’s like water’

That came as a shock to the Americans who shell out hundreds of dollars a month on insulin, a number of whom posted triple-digit pharmacy bills to social media immediately after the president’s assertion.

“I looked at my husband and slapped my leg and said, ‘Can you believe that!’ ” said Tiffany Garrioch, 36, a public health nurse and educator in Minnesota with Type 1 diabetes, who watched the debate with her family.

“We’re already an underserved and highly vulnerable population,” she said. “To hear the president say it costs as much as water makes us look like we’re crybabies or liars.”

Insulin costs her $36.76 a day, she said. In 2008, it was $9.81.

Insulin prices have ballooned over two decades, including during the Trump administration. A subset of people enrolled in Medicare drug plans that cap payments at $35 a month are insulated from those costs. Otherwise a patient with diabetes can spend hundreds of dollars on a monthly insulin supply.

A few decades ago, people could pay about $20 per month for insulin, said Jeremy Greene, a primary care physician and medical historian at Johns Hopkins University. “Insulin prices have been a travesty of American pharmaceutical policy.”

The only way Trump’s statement could not be anything but an “out-and-out fabrication,” Greene said, is if insulin were compared to some of the priciest bottled water on Earth — such as the liquid harvested twice a year from melting Arctic polar ice that the doctor once spotted for sale in a Norway airport.

“The cost of insulin is still high for the majority of Americans who need it to survive,” said Laura Friedman, vice president for federal payment policy at the American Diabetes Association, which supports insurance co-pay caps and Medicaid expansion to help people with diabetes afford the drug.

“The ADA and the millions who are living with diabetes look forward to the day when insulin is affordable so that people can stop suffering from the consequences of dangerous practices like rationing insulin due to exorbitant costs,” she said in a statement.

About 1 in 4 patients with diabetes report underusing insulin because of financial pressure, which “effectively means that they are trying to make their insulin stretch, or having difficulty buying groceries or paying utility bills,” said physician Jing Luo, a professor at the University of Pittsburgh’s Center for Pharmaceutical Policy and Prescribing.

Switching to cheaper but less effective forms of insulin, or rationing it, can be devastating. People with diabetes can suffer strokes, kidney failure or death without sufficient insulin.

“The consequence of the untenable price of insulin can be measured in body counts,” Greene said.

Three companies — Eli Lilly, Novo Nordisk and Sanofi — dominate the market for insulin.

Insulin sold by Novo Nordisk, under the brand name NovoLog, was priced at $40 per vial in 2001 and rose to $289 in 2018, as The Washington Post reported last year. Eli Lilly’s Humalog insulin was $275 a vial as of last year, up from

Expanded Medicaid begins in Nebraska after years of dispute

OMAHA, Neb. (AP) — Nebraska will officially offer expanded Medicaid coverage to low-income people starting Thursday after years of wrangling over it in the Legislature, a statewide ballot campaign that led voters to approve it and a nearly two-year rollout that left some people in health care limbo.

The state will provide coverage to 10,288 residents who have signed up so far, a number roughly in line with the state’s projections. State officials expect expanded enrollment to rise to about 90,000 within a few years.

“This expansion is an excellent opportunity” for people who are now eligible, said Dannette Smith, executive director of the Nebraska Department of Health and Human Services.


Nebraska was among several conservative states where state lawmakers and governors declined to expand Medicaid, only to see the issue go to voters. Republican Gov. Pete Ricketts and his GOP predecessor, Dave Heineman, both argued that expansion would be too costly for the state, and lawmakers rejected six attempts in as many years to adopt it as an optional part of President Barack Obama’s 2010 health care law.

The expansion became law in 2018 when voters approved citizen-led measures in Nebraska, Utah and Idaho. Utah and Idaho officials later attached work requirements to their programs.

In Nebraska, the Ricketts administration implemented two tiers of coverage: a “basic” plan available to all newly qualified recipients and a “prime” plan available to people who are working, in school, volunteering or caring for a relative. The prime plan includes coverage for dental and vision care and over-the-counter drugs.

State health officials have defended the expansion’s slower-than-typical launch and their two-tiered approach, calling it a massive undertaking that required numerous layers of federal approval.

Even so, the delays caused a good deal of uncertainty and stress for people who were waiting to enroll, said Molly McCleery, health care access program director for the group Nebraska Appleseed.

“It was extremely difficult for the folks we worked with,” said McCleery, whose group played a major role in bringing the issue to voters. “A lot of people we worked with had long-standing health needs that they needed to get addressed.”

McCleery said that based on the experience of other states that expanded Medicaid, Nebraska is now likely to see a reduction in personal bankruptcies caused by large medical debts. People who aren’t saddled with huge debts are also able to spend more on other goods and services that help the economy, she said.

State officials said they faced several other challenges in expanding Medicaid, including computer system upgrades for processing applicants; hiring more workers; and negotiating new contracts with the private, managed-care companies that will serve Medicaid recipients. The contractors will administer the program, dubbed Heritage Health, with a financial incentive to provide health care services while keeping costs low.

“There was a lot of work that had to go into this,” said Ricketts, who opposed the expansion but promised to follow the will of voters.

Jeremy Brunssen, the state’s interim Medicaid and Long-Term Care director,